| Net Cash Provided by (Used in) Operating Activities |
-183K |
USD |
+55.4% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
50.9K |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
-101K |
USD |
-5583% |
Q3 2024 |
Q1 2026 |
| Common Stock, Shares Authorized |
1B |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
385M |
shares |
+0.31% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-512K |
USD |
-2376% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
3.02M |
USD |
|
Q3 2025 |
Q1 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
3.02M |
USD |
|
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability |
179K |
USD |
-29.5% |
Q3 2025 |
Q1 2026 |
| Depreciation |
38.6K |
USD |
+192% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
101K |
USD |
|
Q3 2024 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
191K |
USD |
-31.8% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability, Current |
91K |
USD |
+1.94% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
92.2K |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
68.1K |
USD |
-24.8% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.07 |
pure |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
12.5K |
USD |
-53.7% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
92.2K |
USD |
|
Q2 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
17.8M |
USD |
+2.24% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
500K |
USD |
|
Q1 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |